The Question of Return

Premium

It was one of the toughest cases Gholson Lyon had come across — and it was not even his patient. Last year, Lyon, who is a practicing physician but also a research scientist at the Center for Applied Genomics at Children's Hospital of Philadelphia, was heading up a study on Ogden Syndrome, a rare Mendelian disorder associated with a distinct combination of an aged appearance, craniofacial anomalies, global developmental delays, and premature death in infants.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.